Basel Medical Group Ltd
BMGL
$4.41
$0.102.32%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | 4.84% | -- | -- | -- | |
| Total Other Revenue | -56.97% | -- | -- | -- | |
| Total Revenue | 4.56% | -- | -- | -- | |
| Cost of Revenue | 7.15% | -- | -- | -- | |
| Gross Profit | 1.11% | -- | -- | -- | |
| SG&A Expenses | -33.91% | -- | -- | -- | |
| Depreciation & Amortization | -3.73% | -- | -- | -- | |
| Other Operating Expenses | 52.86% | -- | -- | -- | |
| Total Operating Expenses | 3.84% | -- | -- | -- | |
| Operating Income | 7.31% | -- | -- | -- | |
| Income Before Tax | 13.01% | -- | -- | -- | |
| Income Tax Expenses | -5.86% | -- | -- | -- | |
| Earnings from Continuing Operations | 16.75% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 16.75% | -- | -- | -- | |
| EBIT | 7.31% | -- | -- | -- | |
| EBITDA | 7.21% | -- | -- | -- | |
| EPS Basic | 16.91% | -- | -- | -- | |
| Normalized Basic EPS | 13.04% | -- | -- | -- | |
| EPS Diluted | 16.91% | -- | -- | -- | |
| Normalized Diluted EPS | 13.04% | -- | -- | -- | |
| Average Basic Shares Outstanding | 0.00% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 0.00% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |